Skip to main content
Erschienen in: Obesity Surgery 8/2021

28.04.2021 | Original Contributions

Five-year Changes in Body Composition in Type 2 Diabetes Mellitus Patients with a BMI < 32.5 kg/m2 Undergoing Laparoscopic Roux-en-Y Gastric Bypass Surgery

verfasst von: Beibei Cui, Xulong Sun, Weizheng Li, Pengzhou Li, Guohui Wang, Zhaomei Yu, Haibo Tang, Jiapu Ling, Xianhao Yi, Liyong Zhu, Shaihong Zhu

Erschienen in: Obesity Surgery | Ausgabe 8/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Information is scarce on the five-year effect of laparoscopic Roux-en-Y Gastric Bypass (LRYGB) on body composition for Type 2 diabetes mellitus (T2DM) patients with a low BMI. This study aimed to evaluate the five-year changes in body composition in a Chinese T2DM cohort with a BMI < 32.5 kg/m2 after LRYGB.

Methods

Twenty-seven T2DM patients were assessed preoperatively (baseline) and 3 months, 6 months, 1 year, 3 years, and 5 years after LRYGB with dual-energy X-ray absorptiometry (DXA).

Results

DXA assessments were completed in 100%, 85%, 85%, 85%, 48%, and 37% at baseline and 3 months, 6 months, 1 year, 3 years, and 5 years, respectively. For the whole body, fat-free mass and muscle mass decreased from 6 months to 5 years after LRYGB (P < 0.05), while bone mineral content decreased at 5 years after LRYGB (P < 0.05). Fat mass of different regions decreased from 3 months to 1 year (P < 0.05), and a similar magnitude of variation was observed in body fat mass percentage. A fat redistribution characterized by the regional fat proportion of trunk and android decreasing and the regional fat proportion of limbs gaining (P < 0.05) occurred at 5 years after LRYGB.

Conclusion

For low BMI patients with T2DM, LRYGB led to a short-term reduction in FM and a lasting reduction in FFM. A metabolically healthy fat redistribution occurring 5 years after LRYGB might be a promising mechanism to explain the lasting benefits of LRYGB for T2DM patients with a low BMI.

Graphical abstract

Literatur
1.
Zurück zum Zitat Wang T, Lu J, Shi L, et al. Association of insulin resistance and β-cell dysfunction with incident diabetes among adults in China: a nationwide, population-based, prospective cohort study. Lancet Diabetes Endocrinol. 2020;8:115–24.CrossRef Wang T, Lu J, Shi L, et al. Association of insulin resistance and β-cell dysfunction with incident diabetes among adults in China: a nationwide, population-based, prospective cohort study. Lancet Diabetes Endocrinol. 2020;8:115–24.CrossRef
3.
Zurück zum Zitat Ikramuddin S, Korner J, Lee WJ, et al. Lifestyle intervention and medical management with vs without Roux-en-Y gastric bypass and control of hemoglobin A1c, LDL cholesterol, and systolic blood pressure at 5 years in the diabetes surgery study. JAMA. 2018;319:266–78.CrossRef Ikramuddin S, Korner J, Lee WJ, et al. Lifestyle intervention and medical management with vs without Roux-en-Y gastric bypass and control of hemoglobin A1c, LDL cholesterol, and systolic blood pressure at 5 years in the diabetes surgery study. JAMA. 2018;319:266–78.CrossRef
4.
Zurück zum Zitat Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes. N Engl J Med. 2017;376:641–51.CrossRef Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes. N Engl J Med. 2017;376:641–51.CrossRef
5.
Zurück zum Zitat Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2015;386:964–73.CrossRef Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2015;386:964–73.CrossRef
6.
Zurück zum Zitat Mechanick JI, Apovian C, Brethauer S, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society Of Anesthesiologists - executive summary. Endocr Pract. 2019;25:1346–59.PubMed Mechanick JI, Apovian C, Brethauer S, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society Of Anesthesiologists - executive summary. Endocr Pract. 2019;25:1346–59.PubMed
7.
Zurück zum Zitat Stefan N. Causes, consequences, and treatment of metabolically unhealthy fat distribution. Lancet Diabetes Endocrinol. 2020;8:616–27.CrossRef Stefan N. Causes, consequences, and treatment of metabolically unhealthy fat distribution. Lancet Diabetes Endocrinol. 2020;8:616–27.CrossRef
8.
Zurück zum Zitat Stefan N, Schick F, Häring HU. Causes, characteristics, and consequences of metabolically unhealthy normal weight in humans. Cell Metab. 2017;26:292–300.CrossRef Stefan N, Schick F, Häring HU. Causes, characteristics, and consequences of metabolically unhealthy normal weight in humans. Cell Metab. 2017;26:292–300.CrossRef
9.
Zurück zum Zitat Iacobini C, Pugliese G, Blasetti Fantauzzi C, et al. Metabolically healthy versus metabolically unhealthy obesity. Metab Clin Exp. 2019;92:51–60.CrossRef Iacobini C, Pugliese G, Blasetti Fantauzzi C, et al. Metabolically healthy versus metabolically unhealthy obesity. Metab Clin Exp. 2019;92:51–60.CrossRef
10.
Zurück zum Zitat Maïmoun L, Lefebvre P, Aouinti S, et al. Acute and longer-term body composition changes after bariatric surgery. Surg Obes Relat Dis. 2019;15:1965–73.CrossRef Maïmoun L, Lefebvre P, Aouinti S, et al. Acute and longer-term body composition changes after bariatric surgery. Surg Obes Relat Dis. 2019;15:1965–73.CrossRef
11.
Zurück zum Zitat Li P, Ji G, Li W, et al. The relationship between BMI, body composition, and fat mass distribution in Rou-en-Y gastric bypass patients. Obes Surg. 2020;30:1385–91.CrossRef Li P, Ji G, Li W, et al. The relationship between BMI, body composition, and fat mass distribution in Rou-en-Y gastric bypass patients. Obes Surg. 2020;30:1385–91.CrossRef
12.
Zurück zum Zitat Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. Jama. 2009;301:2129–40.CrossRef Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. Jama. 2009;301:2129–40.CrossRef
13.
Zurück zum Zitat Li Y, Teng D, Shi X, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. BMJ. 2020;369:m997.CrossRef Li Y, Teng D, Shi X, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. BMJ. 2020;369:m997.CrossRef
14.
Zurück zum Zitat Seki Y, Kasama K, Yasuda K, et al. The effects of laparoscopic sleeve gastrectomy with duodenojejunal bypass on Japanese patients with BMI < 35 kg/m2 on type 2 diabetes mellitus and the prediction of successful glycemic control. Obes Surg. 2018;28:2429–38.CrossRef Seki Y, Kasama K, Yasuda K, et al. The effects of laparoscopic sleeve gastrectomy with duodenojejunal bypass on Japanese patients with BMI < 35 kg/m2 on type 2 diabetes mellitus and the prediction of successful glycemic control. Obes Surg. 2018;28:2429–38.CrossRef
15.
Zurück zum Zitat Ji G, Li W, Li P, et al. Effect of Roux-en-Y gastric bypass for patients with type 2 diabetes mellitus and a BMI < 32.5 kg/m2: a 6-year study in Chinese patients. Obes Surg. 2020;30:2631–6.CrossRef Ji G, Li W, Li P, et al. Effect of Roux-en-Y gastric bypass for patients with type 2 diabetes mellitus and a BMI < 32.5 kg/m2: a 6-year study in Chinese patients. Obes Surg. 2020;30:2631–6.CrossRef
16.
Zurück zum Zitat Eriksson Hogling D, Bäckdahl J, Thorell A, et al. Metabolic impact of body fat percentage independent of body mass index in women with obesity remission after gastric bypass. Obes Surg. 2020;30:1086–92.CrossRef Eriksson Hogling D, Bäckdahl J, Thorell A, et al. Metabolic impact of body fat percentage independent of body mass index in women with obesity remission after gastric bypass. Obes Surg. 2020;30:1086–92.CrossRef
17.
Zurück zum Zitat Nuijten MAH, Monpellier VM, Eijsvogels TMH, et al. Rate and determinants of excessive fat-free mass loss after bariatric surgery. Obes Surg. 2020;30:3119–26.CrossRef Nuijten MAH, Monpellier VM, Eijsvogels TMH, et al. Rate and determinants of excessive fat-free mass loss after bariatric surgery. Obes Surg. 2020;30:3119–26.CrossRef
18.
Zurück zum Zitat Zamaninour N, Pazouki A, Kermansaravi M, et al. Changes in body composition and biochemical parameters following laparoscopic one anastomosis gastric bypass: 1-year follow-up. Obes Surg. 2020. Zamaninour N, Pazouki A, Kermansaravi M, et al. Changes in body composition and biochemical parameters following laparoscopic one anastomosis gastric bypass: 1-year follow-up. Obes Surg. 2020.
19.
Zurück zum Zitat Rubino F, Nathan DM, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by International Diabetes Organizations. Diabetes Care. 2016;39:861–77.CrossRef Rubino F, Nathan DM, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by International Diabetes Organizations. Diabetes Care. 2016;39:861–77.CrossRef
20.
Zurück zum Zitat Karpe F, Pinnick KE. Biology of upper-body and lower-body adipose tissue--link to whole-body phenotypes. Nat Rev Endocrinol. 2015;11:90–100.CrossRef Karpe F, Pinnick KE. Biology of upper-body and lower-body adipose tissue--link to whole-body phenotypes. Nat Rev Endocrinol. 2015;11:90–100.CrossRef
21.
Zurück zum Zitat Zhang Q, Chen Y, Li J, et al. A meta-analysis of the effects of bariatric surgery on fracture risk. 2018;19:728-736. Zhang Q, Chen Y, Li J, et al. A meta-analysis of the effects of bariatric surgery on fracture risk. 2018;19:728-736.
22.
Zurück zum Zitat Jaruvongvanich V, Vantanasiri K, Upala S, Ungprasert P. Changes in bone mineral density and bone metabolism after sleeve gastrectomy: a systematic review and meta-analysis. 2019;15:1252-1260. Jaruvongvanich V, Vantanasiri K, Upala S, Ungprasert P. Changes in bone mineral density and bone metabolism after sleeve gastrectomy: a systematic review and meta-analysis. 2019;15:1252-1260.
23.
Zurück zum Zitat Cruz-Jentoft AJ, Sayer AA. Sarcopenia. 2019;393:2636–46. Cruz-Jentoft AJ, Sayer AA. Sarcopenia. 2019;393:2636–46.
24.
Zurück zum Zitat Friedrich AE, Damms-Machado A, Meile T, et al. Laparoscopic sleeve gastrectomy compared to a multidisciplinary weight loss program for obesity--effects on body composition and protein status. 2013;23:1957-1965. Friedrich AE, Damms-Machado A, Meile T, et al. Laparoscopic sleeve gastrectomy compared to a multidisciplinary weight loss program for obesity--effects on body composition and protein status. 2013;23:1957-1965.
25.
Zurück zum Zitat Faria SL, Kelly E, Faria OP. Energy expenditure and weight regain in patients submitted to Roux-en-Y gastric bypass. 2009;19:856-859. Faria SL, Kelly E, Faria OP. Energy expenditure and weight regain in patients submitted to Roux-en-Y gastric bypass. 2009;19:856-859.
26.
Zurück zum Zitat Guida B, Cataldi M, Busetto L, et al. Predictors of fat-free mass loss 1 year after laparoscopic sleeve gastrectomy. 2018;41:1307-15. Guida B, Cataldi M, Busetto L, et al. Predictors of fat-free mass loss 1 year after laparoscopic sleeve gastrectomy. 2018;41:1307-15.
27.
Zurück zum Zitat Ciciliot S, Rossi AC, Dyar KA, Blaauw B, Schiaffino S. Muscle type and fiber type specificity in muscle wasting. 2013;45:2191-9. Ciciliot S, Rossi AC, Dyar KA, Blaauw B, Schiaffino S. Muscle type and fiber type specificity in muscle wasting. 2013;45:2191-9.
28.
Zurück zum Zitat Lundsgaard AM, Kiens B. Gender differences in skeletal muscle substrate metabolism - molecular mechanisms and insulin sensitivity. 2014;5:195. Lundsgaard AM, Kiens B. Gender differences in skeletal muscle substrate metabolism - molecular mechanisms and insulin sensitivity. 2014;5:195.
Metadaten
Titel
Five-year Changes in Body Composition in Type 2 Diabetes Mellitus Patients with a BMI < 32.5 kg/m2 Undergoing Laparoscopic Roux-en-Y Gastric Bypass Surgery
verfasst von
Beibei Cui
Xulong Sun
Weizheng Li
Pengzhou Li
Guohui Wang
Zhaomei Yu
Haibo Tang
Jiapu Ling
Xianhao Yi
Liyong Zhu
Shaihong Zhu
Publikationsdatum
28.04.2021
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 8/2021
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-021-05430-w

Weitere Artikel der Ausgabe 8/2021

Obesity Surgery 8/2021 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.